Skip to content

Opening book details…

About this Medicine article

MGMT-inhibitor in combination with TGF-Î2RI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells by Das, A.; Henderson, F. C.; Alshareef, M.; Porto, G. B. F.; Kanginakudru, I.; Infinger, L. K.; Vandergrift, W. A.; Lindhorst, S. M.; Varma, A. K.; Patel, S. J.; Cachia, D. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Das, A.; Henderson, F. C.; Alshareef, M.; Porto, G. B. F.; Kanginakudru, I.; Infinger, L. K.; Vandergrift, W. A.; Lindhorst, S. M.; Varma, A. K.; Patel, S. J.; Cachia, D.
Publisher
Springer Milan; Springer-Verlag; Springer-Verlag Italia; Springer Science and Business Media LLC (ISSN 1699-048X)
Published
2020
Field
Medicine (Health Sciences)

More by Das, A.; Henderson, F. C.; Alshareef, M.; Porto, G. B. F.; Kanginakudru, I.; Infinger, L. K.; Vandergrift, W. A.; Lindhorst, S. M.; Varma, A. K.; Patel, S. J.; Cachia, D.

Browse all works by Das, A.; Henderson, F. C.; Alshareef, M.; Porto, G. B. F.; Kanginakudru, I.; Infinger, L. K.; Vandergrift, W. A.; Lindhorst, S. M.; Varma, A. K.; Patel, S. J.; Cachia, D.